Cytokines secreted by human Wharton's jelly stem cells inhibit the proliferation of ovarian cancer (OVCAR3) cells in vitro

被引:17
作者
Kalamegam, Gauthaman [1 ,2 ]
Sait, Khalid Hussein Wali [3 ]
Anfinan, Nisreen [3 ]
Kadam, Roaa [1 ]
Ahmed, Farid [1 ]
Rasool, Mahmood [1 ]
Naseer, Mohammad Imran [1 ]
Pushparaj, Peter Natesan [1 ]
Al-Qahtani, Mohammed [1 ]
机构
[1] King Abdulaziz Univ, CEGMR, Prince Majid Rd, Jeddah 21589, Saudi Arabia
[2] AIMST Univ, Fac Med, Bedong 08100, Kelantan, Malaysia
[3] King Abdulaziz Univ Hosp, Fac Med, Dept Obstet & Gynaecol, Jeddah 22252, Saudi Arabia
关键词
stem cells; ovarian cancer; cytokines; chemokines; growth factors; cluster analysis; PROGNOSTIC-FACTORS; T-CELLS; GROWTH; EXPRESSION; SURVIVAL; THERAPY; TUMORS;
D O I
10.3892/ol.2019.10094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cytokines enhance tumour cell recognition via cytotoxic effector cells and are therefore effectively used in cancer immunotherapy. Mesenchymal stem cells have efficient homing potential and have been used to target and inhibit various types of cancer mediated by the release of soluble/bioactive factors. Initial evaluation of the human Wharton's jelly stem cell conditioned medium (hWJSC-CM) and cell lysate (hWJSC-CL) against an ovarian cancer cell line (OVCAR3) demonstrated their inhibitory effect in vitro. The secreted cytokine profile was then studied to understand whether the OVCAR3 inhibitory effect was mediated by the cytokines. Expression of cytokines in OVCAR3 following 48 h treatment with hWJSC extracts, namely the hWJSC-CM (50%) and hWJSC-CL (10 mu g/ml), was evaluated using multiplex cytokine assay. Paclitaxel (5 nM) was used as a positive control. Cytokines tumour necrosis factor , interleukin (IL)-4, IL-6, IL-8, IL-10, IL-13, IL-17, IL-1 and granulocyte colony-stimulating factor, reported to be involved in tumour growth, invasion and migration, were significantly decreased. Cytokines with antitumour effects, namely IL-1 receptor antagonist (IL-1RA), IL-2, IL-2 receptor, IL-5, IL-7, IL-12, IL-15, interferon (IFN)- and IFN-, were mildly increased or decreased. Only the increases in IL-1RA (with paclitaxel, hWJSC-CM and hWJSC-CL) and granulocyte-macrophage colony-stimulating factor (with hWJSC-CL) were statistically significant. The chemokines monocyte chemoattractant protein 1, macrophage inflammatory protein (MIP)-1, MIP-1 and Regulated Upon Activation, Normally T-Expressed, and Secreted were significantly decreased while monokine induced by IFN-, IFN- induced protein 10 and Eotaxin demonstrated mild decreases. The growth factors basic fibroblast growth factor, vascular endothelial growth factor and hepatocyte growth factor were significantly decreased. Heatmaps demonstrated differential fold changes in cytokines and hierarchical cluster analysis revealed 3 major and 7 minor sub-clusters of associated cytokines, chemokines and growth factors. In conclusion, the hWJSC extracts decreased the expression of oncogenic cytokines, chemokines and growth factors, which mediated the inhibition of OVCAR3 cells in vitro.
引用
收藏
页码:4521 / 4531
页数:11
相关论文
共 43 条
  • [1] [Anonymous], FRONT PHYSL
  • [2] Role of Chemokine Network in the Development and Progression of Ovarian Cancer: A Potential Novel Pharmacological Target
    Barbieri, Federica
    Bajetto, Adriana
    Florio, Tullio
    [J]. JOURNAL OF ONCOLOGY, 2010, 2010
  • [3] Bermudez Yira, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P224
  • [4] CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
    Bronger, Holger
    Singer, Judith
    Windmueller, Claudia
    Reuning, Ute
    Zech, Daniela
    Delbridge, Claire
    Dorn, Julia
    Kiechle, Marion
    Schmalfeldt, Barbara
    Schmitt, Manfred
    Avril, Stefanie
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (05) : 553 - 563
  • [5] The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
    Broughton, Sophie E.
    Dhagat, Urmi
    Hercus, Timothy R.
    Nero, Tracy L.
    Grimbaldeston, Michele A.
    Bonder, Claudine S.
    Lopez, Angel F.
    Parker, Michael W.
    [J]. IMMUNOLOGICAL REVIEWS, 2012, 250 : 277 - 302
  • [6] Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors
    Chang, Chun-Jung
    Chen, Yi-Hsiang
    Huang, Kai-Wen
    Cheng, Hao-Wei
    Chan, Suit-Fong
    Tai, Kuo-Feng
    Hwang, Lih-Hwa
    [J]. HEPATOLOGY, 2007, 45 (03) : 746 - 754
  • [7] The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
    Charles, Kellie A.
    Kulbe, Hagen
    Soper, Robin
    Escorcio-Correia, Monica
    Lawrence, Toby
    Schultheis, Anne
    Chakravarty, Probir
    Thompson, Richard G.
    Kollias, George
    Smyth, John F.
    Balkwill, Frances R.
    Hagemann, Thorsten
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) : 3011 - 3023
  • [8] MSC and Tumors: Homing, Differentiation, and Secretion Influence the Therapeutic Potential
    D'souza, Naomi
    Burns, Jorge Sans
    Grisendi, Giulia
    Candini, Olivia
    Veronesi, Elena
    Piccinno, Serena
    Horwitz, Edwin M.
    Paolucci, Paolo
    Conte, Pierfranco
    Dominici, Massimo
    [J]. MESENCHYMAL STEM CELLS: BASICS AND CLINICAL APPLICATION II, 2013, 130 : 209 - 266
  • [9] Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma
    Ding, Liang
    Li, Bing
    Zhao, Ying
    Fu, Yi-Fu
    Hu, Er-Ling
    Hu, Qin-Gang
    Ni, Yan-Hong
    Hou, Ya-Yi
    [J]. TUMOR BIOLOGY, 2014, 35 (10) : 10539 - 10546
  • [10] Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer
    Dobrzycka, Bozena
    Mackowiak-Matejczyk, Beata
    Terlikowska, Katarzyna Maria
    Kulesza-Bronczyk, Bozena
    Kinalski, Maciej
    Terlikowski, Slawomir Jerzy
    [J]. EUROPEAN CYTOKINE NETWORK, 2013, 24 (03) : 106 - 113